Literature DB >> 19225573

DNA Topology and Topoisomerases: Teaching a "Knotty" Subject.

Joseph E Deweese1, Michael A Osheroff, Neil Osheroff.   

Abstract

DNA is essentially an extremely long double-stranded rope in which the two strands are wound about one another. As a result, topological properties of the genetic material, including DNA underwinding and overwinding, knotting, and tangling, profoundly influence virtually every major nucleic acid process. Despite the importance of DNA topology, it is a conceptionally difficult subject to teach, because it requires students to visualize three-dimensional relationships. This article will familiarize the reader with the concept of DNA topology and offer practical approaches and demonstrations to teaching this "knotty" subject in the classroom. Furthermore, it will discuss topoisomerases, the enzymes that regulate the topological state of DNA in the cell. These ubiquitous enzymes perform a number of critical cellular functions by generating transient breaks in the double helix. During this catalytic event, topoisomerases maintain genomic stability by forming covalent phosphotyrosyl bonds between active site residues and the newly generated DNA termini. Topoisomerases are essential for cell survival. However, because they cleave the genetic material, these enzymes also have the potential to fragment the genome. This latter feature of topoisomerases is exploited by some of the most widely prescribed anticancer and antibacterial drugs currently in clinical use. Finally, in addition to curing cancer, topoisomerase action also has been linked to the induction of specific types of leukemia.

Entities:  

Year:  2008        PMID: 19225573      PMCID: PMC2643378          DOI: 10.1002/bmb.20244

Source DB:  PubMed          Journal:  Biochem Mol Biol Educ        ISSN: 1470-8175            Impact factor:   1.160


  49 in total

1.  DNA topoisomerase IIbeta and neural development.

Authors:  X Yang; W Li; E D Prescott; S J Burden; J C Wang
Journal:  Science       Date:  2000-01-07       Impact factor: 47.728

Review 2.  DNA topoisomerases: structure, function, and mechanism.

Authors:  J J Champoux
Journal:  Annu Rev Biochem       Date:  2001       Impact factor: 23.643

Review 3.  Untangling intracellular DNA topology.

Authors:  Olivier Espeli; Kenneth J Marians
Journal:  Mol Microbiol       Date:  2004-05       Impact factor: 3.501

Review 4.  Moving one DNA double helix through another by a type II DNA topoisomerase: the story of a simple molecular machine.

Authors:  J C Wang
Journal:  Q Rev Biophys       Date:  1998-05       Impact factor: 5.318

Review 5.  Eukaryotic DNA topoisomerase II beta.

Authors:  C A Austin; K L Marsh
Journal:  Bioessays       Date:  1998-03       Impact factor: 4.345

Review 6.  Topoisomerase I inhibitors: camptothecins and beyond.

Authors:  Yves Pommier
Journal:  Nat Rev Cancer       Date:  2006-10       Impact factor: 60.716

Review 7.  Topoisomerase II and the etiology of chromosomal translocations.

Authors:  Carolyn A Felix; Christos P Kolaris; Neil Osheroff
Journal:  DNA Repair (Amst)       Date:  2006-07-20

8.  DNA topoisomerase II in therapy-related acute promyelocytic leukemia.

Authors:  Anita R Mistry; Carolyn A Felix; Ryan J Whitmarsh; Annabel Mason; Andreas Reiter; Bruno Cassinat; Anne Parry; Christoph Walz; Joseph L Wiemels; Mark R Segal; Lionel Adès; Ian A Blair; Neil Osheroff; Andrew J Peniket; Marina Lafage-Pochitaloff; Nicholas C P Cross; Christine Chomienne; Ellen Solomon; Pierre Fenaux; David Grimwade
Journal:  N Engl J Med       Date:  2005-04-14       Impact factor: 91.245

Review 9.  The role of genistein and synthetic derivatives of isoflavone in cancer prevention and therapy.

Authors:  Fazlul H Sarkar; Shreelekha Adsule; Subhash Padhye; Sudhir Kulkarni; Yiwei Li
Journal:  Mini Rev Med Chem       Date:  2006-04       Impact factor: 3.862

10.  DNA topoisomerase I is essential in Drosophila melanogaster.

Authors:  M P Lee; S D Brown; A Chen; T S Hsieh
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-15       Impact factor: 11.205

View more
  36 in total

Review 1.  DNA topoisomerases and their poisoning by anticancer and antibacterial drugs.

Authors:  Yves Pommier; Elisabetta Leo; HongLiang Zhang; Christophe Marchand
Journal:  Chem Biol       Date:  2010-05-28

2.  Drug interactions with Bacillus anthracis topoisomerase IV: biochemical basis for quinolone action and resistance.

Authors:  Katie J Aldred; Sylvia A McPherson; Pengfei Wang; Robert J Kerns; David E Graves; Charles L Turnbough; Neil Osheroff
Journal:  Biochemistry       Date:  2011-12-16       Impact factor: 3.162

Review 3.  In front of and behind the replication fork: bacterial type IIA topoisomerases.

Authors:  Claudia Sissi; Manlio Palumbo
Journal:  Cell Mol Life Sci       Date:  2010-02-18       Impact factor: 9.261

4.  Overcoming target-mediated quinolone resistance in topoisomerase IV by introducing metal-ion-independent drug-enzyme interactions.

Authors:  Katie J Aldred; Heidi A Schwanz; Gangqin Li; Sylvia A McPherson; Charles L Turnbough; Robert J Kerns; Neil Osheroff
Journal:  ACS Chem Biol       Date:  2013-09-30       Impact factor: 5.100

5.  Phytochemicals as Anticancer and Chemopreventive Topoisomerase II Poisons.

Authors:  Adam C Ketron; Neil Osheroff
Journal:  Phytochem Rev       Date:  2014-03-01       Impact factor: 5.374

6.  Activity of quinolone CP-115,955 against bacterial and human type II topoisomerases is mediated by different interactions.

Authors:  Katie J Aldred; Heidi A Schwanz; Gangqin Li; Benjamin H Williamson; Sylvia A McPherson; Charles L Turnbough; Robert J Kerns; Neil Osheroff
Journal:  Biochemistry       Date:  2015-01-23       Impact factor: 3.162

7.  Inhibition of human DNA topoisomerase IIα by two novel ellipticine derivatives.

Authors:  Kendra R Vann; Yavuz Ergün; Sevil Zencir; Serkan Oncuoglu; Neil Osheroff; Zeki Topcu
Journal:  Bioorg Med Chem Lett       Date:  2016-02-15       Impact factor: 2.823

8.  Novel xanthone-polyamine conjugates as catalytic inhibitors of human topoisomerase IIα.

Authors:  Elirosa Minniti; Jo Ann W Byl; Laura Riccardi; Claudia Sissi; Michela Rosini; Marco De Vivo; Anna Minarini; Neil Osheroff
Journal:  Bioorg Med Chem Lett       Date:  2017-09-08       Impact factor: 2.823

9.  6,6'-Dihydroxythiobinupharidine as a poison of human type II topoisomerases.

Authors:  Esha D Dalvie; Jacob Gopas; Avi Golan-Goldhirsh; Neil Osheroff
Journal:  Bioorg Med Chem Lett       Date:  2019-06-04       Impact factor: 2.823

Review 10.  Molecular biology of therapy-related leukaemias.

Authors:  Melanie Joannides; David Grimwade
Journal:  Clin Transl Oncol       Date:  2010-01       Impact factor: 3.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.